Rankings
▼
Calendar
HROW Q4 2016 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$6M
Gross Profit
$3M
47.0% margin
Operating Income
-$4M
-60.6% margin
Net Income
-$6M
-105.3% margin
EPS (Diluted)
$-0.32
QoQ Revenue Growth
+19.2%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$3M
Stock-Based Comp.
$684,000
Balance Sheet
Total Assets
$27M
Total Liabilities
$21M
Stockholders' Equity
$6M
Cash & Equivalents
$9M
← FY 2016
All Quarters
Q1 2017 →